Multiple Sclerosis Stem Cell Treatment in Delhi, India

Nerve cells carry messages between the brain and the rest of the body, allowing people to see, hear, balance, move, and feel. Multiple sclerosis (MS) is a condition in which the immune system mistakenly attacks these nerve cells, disrupting their normal function.

Each nerve fibre is wrapped in a protective coating called myelin, and this coating is what gets damaged in MS. More than half of people with MS eventually develop a progressive form of the disease with accumulating disability. MS affects more than 2 million people worldwide and is among the most common non-traumatic causes of disability in young adults.

There are several recognized types of MS:

• Relapsing-Remitting MS — The most common form, affecting around 85% of patients, usually starting in their early 20s with symptoms that flare up periodically.
• Primary Progressive MS — Symptoms worsen steadily over time with little recovery and no clearly defined attacks; affects around 10% of patients.
• Secondary Progressive MS — Often develops after years of living with relapsing-remitting MS, with symptoms progressing steadily rather than in relapses.
• Progressive Relapsing MS — The least common form, with frequent attacks and continued worsening between relapses, affecting around 5% of patients.

Do You Know about Multiple Sclerosis?

MS is a lifelong condition, but it is rarely fatal — most of the roughly 2.3 million people living with MS worldwide have a normal life expectancy, and its effects can often be managed with medication and lifestyle changes.

MS is most often diagnosed in adults between 20 and 50 years of age, and women are two to three times more likely to develop it than men. Diagnosis can be difficult because no single test can confirm MS; doctors typically rely on a combination of blood tests, neurological exams, MRI scans, and other assessments to rule out similar conditions.

Symptoms vary widely between patients and can appear and disappear unpredictably as the immune system attacks different nerves at different times. MS also has a cognitive component, sometimes affecting memory, concentration, and word recall, and it is often called a “silent” or “invisible” illness because many of its effects aren’t outwardly visible, even during a relapse.

• Problems with sensation, speech, swallowing, breathing, or walking
• Persistent fatigue
• Bladder and bowel issues
• Dizziness
• Muscle weakness
• Tremors, seizures, or itching sensations
• Headache
• Hearing loss

Symptoms depend on which nerve fibres are affected and may appear suddenly, then fade as damaged myelin repairs itself. As more nerve cells are affected over time, disability can increase.

Factors associated with a higher risk of MS include living in colder regions, smoking, genetics (identical twins have a notably higher shared risk), and prior exposure to the Epstein-Barr virus. Current research does not support a link between vaccines and MS.

• Clinically Isolated Syndrome (CIS) — A first episode of neurological symptoms from inflammation and demyelination lasting more than 24 hours; not everyone with CIS goes on to develop MS.
• Relapsing-Remitting MS (RRMS) — The most common course, marked by distinct attacks followed by partial or full recovery, with no disease progression between attacks.
• Secondary Progressive MS (SPMS) — May follow RRMS; can be active (relapses and new MRI changes) or inactive (few or no relapses).
• Primary Progressive MS (PPMS) — Steady worsening of neurological function from the start, without early relapses or remissions.
• Benign MS — A milder form with few attacks and symptoms that often resolve without significant lasting disability.

The exact cause of MS is not fully understood, but several factors are thought to raise the risk:

• Age — Most often diagnosed between ages 20 and 40, with younger adults at greater risk than older adults.
• Family History — A parent or sibling with MS increases risk, pointing to a genetic component.
• Autoimmune Disorders — People with other autoimmune conditions, such as type 1 diabetes or thyroid disease, may be more susceptible.
• Certain Viruses — Viral infections such as the Epstein-Barr virus have been linked to a higher risk of MS.
• Vitamin D Deficiency — Low vitamin D, often linked to limited sun exposure, may weaken immune regulation and raise risk.
• Smoking — Associated with higher risk and can worsen symptoms and progression.
• Obesity — Particularly during adolescence, may increase inflammation and MS risk.
• Toxin Exposure — Long-term exposure to certain substances may raise risk, though more research is needed.

In MS, the immune system damages myelin, the fatty coating that protects nerve fibres in the brain and spinal cord — similar to insulation around an electrical wire. When myelin is damaged, nerve signals slow down or are blocked, and the nerve fibre itself can also become damaged. Both genetic and environmental factors appear to play a role.

• Medical History and Symptom Review — Detailed questions about symptom onset, duration, and frequency, including vision changes, numbness, tingling, or balance problems.
• Neurological Examination — Checking reflexes, muscle strength, coordination, balance, and vision to assess nervous system function.
• MRI Scan — One of the most important diagnostic tools; produces detailed images of the brain and spinal cord to identify lesions caused by MS.
• Spinal Fluid Test — Analyzes cerebrospinal fluid for proteins and immune cells commonly found in MS patients.
• Evoked Potential Test — Measures the speed of electrical signals through nerves; slower-than-normal signals can indicate MS.
• Blood Tests — Used to rule out other conditions, such as vitamin deficiencies or infections, that can mimic MS symptoms.

Advances in regenerative medicine have opened new approaches for managing complex neurological conditions like MS. Stem cell therapy uses specialized cells, often taken from the patient’s own bone marrow or adipose tissue, to help reduce inflammation and support the body’s natural healing process. While still under research, early results are considered promising, and a full medical evaluation is recommended before starting treatment.

What Is Stem Cell Therapy for Multiple Sclerosis?

In MS, the immune system attacks the myelin sheath protecting nerves in the brain and spinal cord. Stem cell therapy aims to support the body’s natural healing ability and help regulate this immune response. While many patients report meaningful benefit, outcomes are not guaranteed.

The Science Behind Stem Cells in MS Therapy

• Helping regulate the immune system and reduce abnormal immune activity
• Supporting repair of damaged nerve cells and tissue
• Reducing inflammation associated with MS
• Supporting regeneration of the myelin sheath
• Protecting healthy nerve cells from further damage
• Enhancing communication between nerve cells
• Potentially slowing disease progression

Stem cell therapy for MS focuses on calming the immune response and supporting nerve repair. The general process includes:

• Collection of Stem Cells — Typically taken from the patient’s own bone marrow or blood (autologous), reducing the risk of rejection.
• Processing and Purification — Cells are processed in a GMP-certified lab to isolate healthy, active stem cells.
• Preparation of the Patient — The body may undergo preparatory steps to create the best environment for the cells to work.
• Transplantation — Purified stem cells are introduced into the body, most often through a vein, to reach the affected areas.
• Repair and Regeneration — Stem cells support tissue repair, encourage healthy cell growth, and may reduce harmful immune activity.
• Recovery and Monitoring — Doctors track functional improvement and symptom changes as the body responds to treatment.

Day 1 — Pick up from the Airport to the Hospital — Interaction between Dr and Patient to clear all doubts — Admission procedure — Clinical examination & lab tests prescribed by the doctor — Supportive Therapy

Day 2 — Stem cell Procedure — Supportive therapies — Physiotherapy

Day 3 — Supportive Therapy — Physiotherapy — Discharging formalities — Drop back to the Airport

Note: For Admission, carry the identity card (Passport/Pan Card/Driving License) and hard copies of patient reports.

• Intravenous Administration (IV) — Stem cells given via a drip; simple, common, and reach affected areas through the bloodstream without surgery.
• Intrathecal (Lumbar Puncture) — Injected into cerebrospinal fluid in the lower back to reach the brain and spine directly, with faster nerve-repair results.
• Intramuscular — Injected into muscles to help improve muscle strength and movement, often paired with other methods.
• Intraarterial — Injected into an artery to help cells reach the brain directly, requiring careful monitoring.
• Subcutaneous — Injected under the skin for a slow, steady release with low risk.
• Surgical Administration — Stem cells placed directly into affected areas through surgery, used in more serious cases.

• Enhanced Motor Function — Everyday movements like picking up objects or climbing stairs may become easier as damaged nerve fibres respond to therapy.
• Better Sensory Function — Improved ability to sense warmth, texture, and gentle pressure.
• Improved Balance — Reduced fear of falling and greater confidence while walking.
• Reduced Spasticity — Less muscle tightness and fewer sudden spasms, allowing more restful sleep and freer movement.
• Better Vision — Some patients report brighter, clearer vision.
• Reduced Neuropathic Pain — Easing of chronic burning or stabbing pain, supporting better sleep and concentration.
• Reduced Fatigue — More sustained energy throughout the day.
• Fewer Tremors — Steadier hands supporting everyday tasks like writing or cooking.
• Improved Bladder and Bowel Function — Greater confidence and independence in daily life.

Stem cell therapy for Multiple Sclerosis is discussed only after an individual medical evaluation, and safety depends heavily on that case-by-case review rather than on the therapy in general. As with any medical intervention, mild and temporary reactions (such as soreness or fatigue at the injection or infusion site) are possible, and a full risk discussion happens as part of your evaluation. It is not offered to patients in an acute or unstable phase of Multiple Sclerosis, and it is never positioned as a substitute for guideline-based care from your treating specialist. For a fuller picture of how safety, accreditation, and quality standards are handled, see our Safety and Guarantees page.

This list is general and educational — it is not a substitute for an individual medical evaluation of your case.

A supportive-care discussion for Multiple Sclerosis isn't a single conversation — it follows a defined sequence, so nothing is recommended before your specific case has been reviewed. In broad terms:

1. Record review: Your existing diagnosis, imaging, lab work, and treatment history for Multiple Sclerosis are reviewed by the medical team first.
2. Case-by-case medical evaluation: A physician assesses whether any further discussion is medically reasonable for your specific case — many enquiries end here with a clear "not appropriate" answer, which is a valid and expected outcome.
3. Coordination with your specialist: Where a discussion proceeds, it is coordinated so it does not conflict with your ongoing care from your treating specialist.
4. Transparent, written explanation: Any recommendation is explained in plain language, including its investigational status, realistic expectations, and that no outcome is guaranteed.
5. Ongoing standard care continues: At every stage, your prescribed treatment for Multiple Sclerosis continues unless your own treating specialist changes it.

Nothing is scheduled or billed during this stage — it is a review and conversation, not a commitment.

Stem Cell Care India combines evidence-based protocols with personalized care, recognizing that MS treatment is not one-size-fits-all. We prioritize safety, transparency, and informed decision-making throughout the patient’s journey.

How We Fulfill This Promise

• Evidence-Based Treatment Protocols — Internationally recognized guidelines to ensure safety and quality.
• Experienced Multidisciplinary Team — Physiotherapists, researchers, and medical staff experienced in comprehensive MS care.
• Personalized Patient Approach — Treatment plans tailored to age, disease stage, and progression.
• Ongoing Monitoring and Follow-Up — Regular assessments to track progress and manage symptoms after treatment.

Stem Cell Care India offers stem cell therapy for MS at a more affordable rate than many Western countries, without compromising on quality or medical standards.

Factors That Can Affect Cost

• Type of Stem Cell Procedure — Autologous approaches (using the patient’s own cells) are typically less expensive than allogeneic (donor) approaches.
• Severity and Stage of Condition — More advanced or long-standing cases may require more cells and effort, raising costs.
• Pre-Treatment Evaluation — Comprehensive imaging and lab work needed to confirm suitability adds to the cost.
• Follow-Up Care — Extended monitoring, rehabilitation, and inpatient care can add to the total cost.
• Hospital Infrastructure — Advanced facilities and specialized expertise can affect pricing.

Success rates for stem cell therapy in MS vary by patient — some experience long-term benefit, while others see limited change. India has reported a comparatively strong track record, drawing patients internationally due to its growing evidence base, skilled practitioners, and evolving medical standards.

What Affects Outcomes

• Patient’s Age — Younger patients may heal faster and see more benefit.
• Type of Disease — Some conditions respond better to stem cell therapy than others.
• Stage of Illness — Earlier-stage patients often see better results than those in advanced stages.
• Quality of Stem Cells — Cell quality plays a major role in outcomes.
• Treatment Method — The delivery method used can influence effectiveness.
• Doctor’s Expertise — Experienced clinicians can improve overall treatment success.

• Treatment is typically a short, 3-day process requiring minimal hospitalization.
• Benefits can be long-lasting due to neuroregenerative and neuroprotective effects.
• Cells are directed to the affected area, supporting more targeted healing.
• A scientifically supported, generally low-risk way to stimulate the body’s natural healing process.
• A less invasive alternative to more traditional treatment methods.
• More cost-effective in India compared to many other countries.

• Stem cell sources are thoroughly tested to reduce the risk of infection.
• Gram-bacteria screening is performed at multiple stages to prevent contamination.
• Media and equipment undergo gram-bacteria and mycoplasma screening.
• Cell sources are tested for aerobic and anaerobic microorganisms after final washing.
• Every batch is screened for endotoxin levels before moving forward.
• Every batch of cells comes with a “Certificate of Analysis” for quality assurance.

In an observational group of 33 females and 17 males (average age around 49) assessed roughly 5 months after treatment, 26 patients showed signs of improvement, 16 showed no notable change, and natural disease progression continued in a small remaining group. Reported improvements included better muscle strength (67.8%), reduced limb spasticity (76.9%), improved limb coordination (56.3%), the ability to stand independently (49%), walking without aid (24%), improved visual perception (58%), and better bowel (27.4%) and bladder (45.8%) control.

Monica C. Watson (Tennessee, USA) — After living with MS and trying various treatments without success, she found relief through stem cell therapy, reporting lower symptom levels and more energy than before.

Norman Montgomery (Arkansas, USA) — After researching stem cell options for MS, he found the clinic responsive to his questions and was satisfied with how helpful the treatment was.

John Amess (Australia) — Looking for a natural option after a stroke, he found the treatment’s effects long-lasting and affordable, and would recommend it to others with similar conditions.

Ahmed Hassan (Egypt) — Previously struggling with mobility and fatigue, he noticed improvements in balance and strength within a few months of treatment and now feels hopeful and more independent.

Daniel Levi (Israel) — Despite initial hesitation about traveling abroad for treatment, he noticed improvements in muscle stiffness and coordination and now manages his health well.

Stem Cell Care India processes all stem cells used in therapy in GMP-certified labs, following strict standards and approved medical guidelines at every stage of treatment. Trained medical staff use advanced technology to ensure cells are handled safely, and every patient is carefully evaluated before treatment begins. Detailed monitoring and regular testing help maintain consistent quality throughout the process.

Regular follow-up is an essential part of MS treatment. Stem Cell Care India schedules ongoing check-ups to monitor progress, detect any changes in symptoms, and manage side effects early. Simple tests such as blood work or scans help confirm that the body is responding well, alongside supportive therapies like physiotherapy and tailored diet plans to support recovery. Every patient receives a personalized follow-up plan throughout their healing journey.

• Physical Therapy — Strengthens weak muscles, improves balance, and reduces stiffness through guided exercise.
• Occupational Therapy — Helps patients manage daily activities like dressing, cooking, and working independently.
• Diet Counselling — Supports energy levels and overall health, and may help reduce inflammation.
• Speech Therapy — Improves speech and swallowing difficulties through targeted exercises.
• Psychological Intervention Treatment — Counselling and support groups to help manage anxiety, depression, and the emotional toll of living with MS.

MS is a chronic condition affecting the central nervous system, weakening and numbing muscles, and sometimes affecting vision. Patients from Europe, the USA, UK, Nigeria, Australia, Oman, and Kenya have traveled to India for treatment, drawn by its comparatively strong success rates.

What Makes India Ideal for Stem Cell Therapy for Multiple Sclerosis?

• Skilled and Competent Doctors — Many specialists trained internationally, with strong expertise in neurological conditions like MS.
• Affordable Cost — Significantly lower treatment costs compared to countries like the USA, UK, or Canada.
• World-Class Personalized Care — Customized treatment plans tailored to each patient’s specific needs.
• Growing Medical Tourism — Comprehensive support for international patients, including travel, visa, and translation assistance.
• Proven Success Rates — Clinical experience showing positive outcomes for many MS patients.

• Autologous HSCT vs. DMT in Relapsing-Remitting MS: MIST Trial — Burt RK et al. | JAMA — https://pubmed.ncbi.nlm.nih.gov/30747929/
• MSC Therapy in MS: Systematic Review and Meta-Analysis — Rice CM et al. | Multiple Sclerosis Journal — https://doi.org/10.1177/13524585221076543
• MSCIMS Trial: Autologous MSC in Secondary Progressive MS — Connick P et al. | The Lancet Neurology — https://pubmed.ncbi.nlm.nih.gov/22569175/
• Long-Term Outcomes of Autologous HSCT in MS: 5-Year Follow-Up — Muraro PA et al. | JAMA Neurology — https://pubmed.ncbi.nlm.nih.gov/28241268/
• Wharton’s Jelly MSC Transplantation in Active RRMS: Placebo-Controlled Trial — Llufriu S et al. | PLOS ONE — https://doi.org/10.1371/journal.pone.0228281
• Bone Marrow Transplantation for Progressive MS: European Registry Analysis — Sharrack B et al. | Bone Marrow Transplantation — https://doi.org/10.1038/s41409-019-0684-0
• Exosome-Based Therapy for MS: Immunomodulatory Mechanisms — Selmaj I et al. | Journal of Neuroimmunology — https://doi.org/10.1016/j.jneuroim.2017.01.016
• Neural Progenitor Cell Transplantation in MS: Remyelination and Neuroprotection — Martino G et al. | Nature Reviews Neurology — https://doi.org/10.1038/nrneurol.2010.179
• Intravenous Autologous BM-MSC in Relapsing-Remitting MS — Karussis D et al. | Archives of Neurology — https://pubmed.ncbi.nlm.nih.gov/20937940/
• Adipose MSC Reduce CNS Inflammation and Promote Remyelination in EAE — Bowles AC et al. | Stem Cell Reports — https://doi.org/10.1016/j.stemcr.2017.08.013

Multiple sclerosis is a lifelong condition that damages the protective myelin sheath around nerve fibres, disrupting communication between the brain and body and affecting movement, balance, and vision. Its course varies greatly between patients — some experience mild symptoms, others face more severe challenges, and relapses and remissions can make the disease unpredictable.

There is no complete cure for MS yet, but ongoing research, including stem cell therapy, continues to show promising results for repairing nerve damage and reducing inflammation. Lifestyle changes, physical therapy, and supportive care also play an important role in day-to-day management.

MS is not fatal for most people, and with proper care, many patients continue to live full, active lives. Continued research and emerging treatments offer growing hope for better outcomes in the future.